Published online before print October 7, 2002, doi: 10.1161/01.CIR.0000035650.05921.50
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:2250.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Dual Effect of Ceramide on Human Endothelial Cells
Induction of Oxidative Stress and Transcriptional Upregulation of Endothelial Nitric Oxide Synthase
From the Department of Pharmacology (H.L., P.J., C.B., T.W., U.F.), Johannes Gutenberg University, Mainz, Germany; Pharmazentrum Frankfurt (A.H., J.P.), Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany; and Department of Pathophysiology (H.L.), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Correspondence to Ulrich Förstermann, MD, PhD, Department of Pharmacology, Johannes Gutenberg University, Obere Zahlbacher Strasse 67, D-55131 Mainz, Germany. E-mail Ulrich.Forstermann{at}Uni-Mainz.de
Background— Generation of the second-messenger molecule ceramide by stimulated sphingomyelinase activity has been implicated in the inflammatory processes contributing to the pathogenesis of atherosclerosis. However, reports of stimulatory effects of ceramide on endothelial NO production in animal models suggest antiatherosclerotic effects of the molecule. Therefore, we investigated long-term effects of ceramide on NO generation in human endothelial cells.
Methods and Results— In human umbilical vein endothelial cells (HUVECs) and in HUVEC-derived EA.hy 926 endothelial cells, C6-ceramide (N-hexanoyl-D-erythro-sphingosine) reduced the generation of bioactive NO (RFL-6 reporter-cell assay). At the same time, the signaling molecule increased endothelial NO synthase (eNOS) mRNA (RNase protection assay) and protein expression (Western blot). C6-ceramide stimulated eNOS transcription by a signaling mechanism involving protein phosphatase PP2A but did not modify the stability of the eNOS mRNA. Endothelial generation of reactive oxygen species (ROS) was increased by C6-ceramide [5-(and-6)-chloromethyl-2', 7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) oxidation-based fluorescence assay], and this effect was partially reversed by the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME). On the other hand, (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4) normalized in part the ceramide-induced reduction in bioactive NO.
Conclusions— Ceramide produces oxidative stress in human endothelial cells, thereby reducing bioactive NO. The partial reversal of this reduction by BH4 and the diminution of ROS generation by L-NAME suggest that ceramide promotes NADPH oxidase activity of eNOS, leading to ROS formation at the expense of NO synthesis. The ceramide-induced upregulation of eNOS gene transcription can be considered an ineffective compensatory mechanism. The decreased bioavailability of NO is likely to favor a proatherogenic role of ceramide.
Key Words: atherosclerosis • endothelium-derived factors • nitric oxide synthase • signal transduction
This article has been cited by other articles:
 |
|
 |
|
  W. L. Holland and S. A. Summers Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism Endocr. Rev., June 1, 2008; 29(4): 381 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Shah, G. Yang, I. Lee, J. Bielawski, Y. A. Hannun, and F. Samad Protection from High Fat Diet-induced Increase in Ceramide in Mice Lacking Plasminogen Activator Inhibitor 1 J. Biol. Chem., May 16, 2008; 283(20): 13538 - 13548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, P. Czerwinski, M. Hortmann, H.-Y. Sohn, U. Forstermann, and H. Li Protein kinase C {alpha} promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor Cardiovasc Res, May 1, 2008; 78(2): 349 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Steinkamp-Fenske, L. Bollinger, H. Xu, Y. Yao, S. Horke, U. Forstermann, and H. Li Reciprocal Regulation of Endothelial Nitric-Oxide Synthase and NADPH Oxidase by Betulinic Acid in Human Endothelial Cells J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Dudzinski and T. Michel Life history of eNOS: Partners and pathways Cardiovasc Res, July 15, 2007; 75(2): 247 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zahlten, B. Riep, F.C. Nichols, C. Walter, B. Schmeck, J.-P. Bernimoulin, and S. Hippenstiel Porphyromonas gingivalis Dihydroceramides Induce Apoptosis in Endothelial Cells J. Dent. Res., July 1, 2007; 86(7): 635 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Traupe, C. D. Stettler, H. Li, E. Haas, I. Bhattacharya, R. Minotti, and M. Barton Distinct Roles of Estrogen Receptors {alpha} and {beta} Mediating Acute Vasodilation of Epicardial Coronary Arteries Hypertension, June 1, 2007; 49(6): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Samad, K. D. Hester, G. Yang, Y. A. Hannun, and J. Bielawski Altered Adipose and Plasma Sphingolipid Metabolism in Obesity: A Potential Mechanism for Cardiovascular and Metabolic Risk Diabetes, September 1, 2006; 55(9): 2579 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, K. Witte, M. August, I. Brausch, U. Godtel-Armbrust, A. Habermeier, E. I. Closs, M. Oelze, T. Munzel, and U. Forstermann Reversal of Endothelial Nitric Oxide Synthase Uncoupling and Up-Regulation of Endothelial Nitric Oxide Synthase Expression Lowers Blood Pressure in Hypertensive Rats J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2536 - 2544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jacobi, S. Sela, H. I. Cohen, J. Chezar, and B. Kristal Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2051 - H2058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-a Kim, M. Montagnani, K. K. Koh, and M. J. Quon Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms Circulation, April 18, 2006; 113(15): 1888 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Defoort, P. M. Kim, and L. M. Winn Valproic Acid Increases Conservative Homologous Recombination Frequency and Reactive Oxygen Species Formation: A Potential Mechanism for Valproic Acid-Induced Neural Tube Defects Mol. Pharmacol., April 1, 2006; 69(4): 1304 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, N. Xia, I. Brausch, Y. Yao, and U. Forstermann Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 926 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Xu, K. Ikeda, and Y. Yamori Upregulation of Endothelial Nitric Oxide Synthase by Cyanidin-3-Glucoside, a Typical Anthocyanin Pigment Hypertension, August 1, 2004; 44(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsunaga, S. Kotamraju, S. V. Kalivendi, A. Dhanasekaran, J. Joseph, and B. Kalyanaraman Ceramide-induced Intracellular Oxidant Formation, Iron Signaling, and Apoptosis in Endothelial Cells: PROTECTIVE ROLE OF ENDOGENOUS NITRIC OXIDE J. Biol. Chem., July 2, 2004; 279(27): 28614 - 28624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Malo, F. Desjardins, J.-F. Tanguay, J.-C. Tardif, M. Carrier, and L. P. Perrault Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model Cardiovasc Res, August 1, 2003; 59(2): 501 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, C. Burkhardt, U.-R. Heinrich, I. Brausch, N. Xia, and U. Forstermann Histamine Upregulates Gene Expression of Endothelial Nitric Oxide Synthase in Human Vascular Endothelial Cells Circulation, May 13, 2003; 107(18): 2348 - 2354. [Abstract] [Full Text] [PDF]
|
|